These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Rand JH; Wu XX; Quinn AS; Chen PP; Hathcock JJ; Taatjes DJ Blood; 2008 Sep; 112(5):1687-95. PubMed ID: 18577708 [TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome. Belizna C Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016 [TBL] [Abstract][Full Text] [Related]
6. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production? de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747 [TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus. Broder A; Putterman C J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353 [TBL] [Abstract][Full Text] [Related]
8. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity. Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808 [TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome. Arachchillage DJ; Laffan M; Pericleous C Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847 [TBL] [Abstract][Full Text] [Related]
10. Clinical profiles and risk assessment in patients with antiphospholipid antibodies. Kato M; Hisada R; Atsumi T Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978 [TBL] [Abstract][Full Text] [Related]
11. Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018? Zuo Y; Barbhaiya M; Erkan D Curr Rheumatol Rep; 2018 Sep; 20(11):66. PubMed ID: 30203272 [TBL] [Abstract][Full Text] [Related]
12. Serological evolution in women with positive antiphospholipid antibodies. Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307 [TBL] [Abstract][Full Text] [Related]